The Patent Finder

Telik, Inc.

Also on record
Records under this name other than patents Telik, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Telik, Inc.

PatentTitleStatus Expires Confidence
US 6,506,739Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
Term ended
Term ended May 1, 2021 · From the USPTO record
Term endedTerm ended May 1, 2021From the USPTO record
US 8,334,266Process for and intermediates in the preparation of canfosfamide and its salts
Formerly held
Lapsed on the fee record
Ended Dec 18, 2020 · From the USPTO record
Lapsed on the fee recordEnded Dec 18, 2020From the USPTO record
US 8,093,231Sulfonylethyl phosphorodiamidates
Lapsed on the fee record
Ended Jan 10, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jan 10, 2020From the USPTO record
US 6,337,338Heteroaryl-aryl ureas as IGF-1 receptor antagonists
Formerly held
Term ended
Term ended Dec 15, 2019 · From the USPTO record
Term endedTerm ended Dec 15, 2019From the USPTO record
US 6,054,286Methods to identify immunomodulators using cognate interaction of PKC-theta
Formerly held
Term ended
Term ended Jan 15, 2019 · From the USPTO record
Term endedTerm ended Jan 15, 2019From the USPTO record
US 8,841,476Preparation of crystalline ezatiostat hydrochloride ansolvate form D
Lapsed on the fee record
Ended Sep 23, 2018 · From the USPTO record
Lapsed on the fee recordEnded Sep 23, 2018From the USPTO record
US 8,759,303Compositions and methods for treating myelodysplastic syndrome
Lapsed on the fee record
Ended Jun 24, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jun 24, 2018From the USPTO record
US 8,716,521Formulations of canfosfamide and their preparation
Lapsed on the fee record
Ended May 6, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 6, 2018From the USPTO record
US 7,029,695Therapeutic compositions containing glutathione analogs
Lapsed on the fee record
Ended Apr 18, 2018 · From the USPTO record
Lapsed on the fee recordEnded Apr 18, 2018From the USPTO record
US 6,992,086Antagonists of MCP-1 function and methods of use thereof
Lapsed on the fee record
Ended Jan 31, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jan 31, 2018From the USPTO record
10 of 77 patents shown.
Pro members see all 77.
Pro members: see all 77 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited